Results 21 to 30 of about 7,902 (150)

Precision Stereotactic Radiotherapy for Spinal Tumors: Mechanism, Efficacy, and Issues

Frontiers in Oncology, 2020
Stereotactic ablative radiotherapy (SABR/SBRT) is a revolutionary technique for tumor therapy. Its advantages are especially beneficial for the treatment spinal tumors.
Hongqing Zhuang, Hongxia Zhuang, Ning Lang, Jiandong Liu   +3 more
doaj   +1 more source

Is SABR cost-effective in oligometastatic cancer?: An economic analysis of the SABR-COMET randomized trial

, 2021
Purpose: The phase 2 randomized study SABR-COMET demonstrated that in patients with controlled primary tumors and 1 to 5 oligometastatic lesions, SABR was associated with improved progression-free survival (PFS) compared with standard of care (SoC), but ...
Liu, Mitchell, Gaede, Stewart, Zaric, Gregory S., Schellenberg, Devin, Rodrigues, George B., Palma, David A., Mulroy, Liam A., Qu, X. Melody, Warner, Andrew, Senan, Suresh, Chen, Yujie, Harrow, Stephen, Swaminath, Anand, Kopek, Neil, Louie, Alexander V., John-Baptiste, Ava, Senthi, Sashendra, Olson, Robert A.   +17 more
core   +1 more source

Salvage Post-Operative Stereotatic Ablative Radiotherapy for Re-Current Squamous Cell Carcinoma of Head and Neck

Medicina, 2022
Background and Objectives: Patients with recurrent squamous cell carcinoma of the head and neck (rHNC) face an aggressive disease. Surgical resection is the gold standard treatment. Immediate adjuvant post-operative stereotactic ablative radiotherapy (PO-
Antonio Pellizzon, Maria Silva, Ricardo Fogaroli, Elson Neto, Michael Chen, Guilherme Godim, Douglas Castro, Henderson Ramos, Carolina Abrahao   +8 more
doaj   +1 more source

Study protocol of the LARK (TROG 17.03) clinical trial: a phase II trial investigating the dosimetric impact of Liver Ablative Radiotherapy using Kilovoltage intrafraction monitoring

BMC Cancer, 2021
Background Stereotactic Ablative Body Radiotherapy (SABR) is a non-invasive treatment which allows delivery of an ablative radiation dose with high accuracy and precision. SABR is an established treatment for both primary and secondary liver malignancies,
Yoo Young Dominique Lee, Doan Trang Nguyen, Trevor Moodie, Ricky O’Brien, Anne McMaster, Andrew Hickey, Nicole Pritchard, Per Poulsen, Elizaveta Mitkina Tabaksblat, Britta Weber, Esben Worm, David Pryor, Julie Chu, Nicholas Hardcastle, Jeremy Booth, Val Gebski, Tim Wang, Paul Keall   +17 more
doaj   +1 more source

TAVBA VA SABR RAMZI

, 2022
Ushbu maqolada Ayyub alayhissalom haqida ma‘lumot keltirish orqali uning sabr ramzi sifatida ifodalanishi izohlab ...
Ashurova Hamida Aliyor qizi
core   +1 more source

Current Understanding of Ablative Radiation Therapy in Hepatocellular Carcinoma

Journal of Hepatocellular Carcinoma, 2021
Ashwathy S Mathew,1 Laura A Dawson2,3 1Department of Radiation Oncology, Apollo Proton Cancer Centre, Chennai, Tamil Nadu, India; 2Radiation Medicine Program, Princess Margaret Cancer Centre, Toronto, Ontario, Canada; 3Department of Radiation Oncology ...
Mathew AS, Dawson LA
doaj  

Advances in Radiobiology of Stereotactic Ablative Radiotherapy

Frontiers in Oncology, 2020
Radiotherapy (RT) has been developed with remarkable technological advances in recent years. The accuracy of RT is dramatically improved and accordingly high dose radiation of the tumors could be precisely projected.
Bin Qiu, Abudureyimujiang Aili, Lixiang Xue, Ping Jiang, Junjie Wang   +4 more
doaj   +1 more source

Increased CD8+CD28+ T cells independently predict better early response to stereotactic ablative radiotherapy in patients with lung metastases from non-small cell lung cancer

Journal of Translational Medicine, 2019
Background Stereotactic ablative radiotherapy (SABR) shows a remarkable local control of non-small cell lung cancer (NSCLC) metastases, partially as a result of host immune status. However, the predictors of immune cells for tumor response after SABR are
Chao Liu, Qinyong Hu, Kai Hu, Huichao Su, Fang Shi, Li Kong, Hui Zhu, Jinming Yu   +7 more
doaj   +1 more source

Stereotactic ablative radiotherapy versus conventionally fractionated radiotherapy in the treatment of hepatocellular carcinoma with portal vein invasion: a retrospective analysis

Radiation Oncology, 2019
Background This study aimed to compare the clinical outcomes of stereotactic ablative radiotherapy (SABR) and conventionally fractionated radiotherapy (CFRT) in hepatocellular carcinoma (HCC) patients with portal vein invasion (PVI). Methods HCC patients
Jen-Fu Yang, Cheng-Hsiang Lo, Meei-Shyuan Lee, Chun-Shu Lin, Yang-Hong Dai, Po-Chien Shen, Hsing-Lung Chao, Wen-Yen Huang   +7 more
doaj   +1 more source

Radiation-Induced Peripheral Neuropathy After Thoracic Stereotactic Ablative Radiotherapy: Case Report

JTO Clinical and Research Reports, 2022
Stereotactic ablative radiotherapy (SABR) is a highly effective treatment for medically inoperable patients with early stage NSCLC. Because of its noninvasive nature and favorable toxicity profile, the use of SABR continues to expand for eligible ...
Ha H. Pham, MD, PhD, Neil Newman, MD, Evan C. Osmundson, MD, PhD   +2 more
doaj   +1 more source